New Approach for Treating Idiopathic Pulmonary Fibrosis

Researchers at Helmholtz Zentrum München, in collaboration with an international team, have identified a potential novel drug target for idiopathic pulmonary fibrosis, a dangerous chronic lung disease. They elucidated a new mechanism of fibrosis formation that plays an important role in the pathogenesis of the disease. These findings have now been published in the leading scientific journal American Journal of Respiratory and Critical Care Medicine. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)